Published in Infect Immun on April 01, 1983
Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis (2009) 3.12
Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study. Am J Kidney Dis (2009) 1.22
Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis (2005) 1.09
Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective. PLoS One (2011) 1.00
Serologic vaccination response after solid organ transplantation: a systematic review. PLoS One (2013) 0.89
Pathogenicity of pandemic H1N1 influenza A virus in immunocompromised cynomolgus macaques. PLoS One (2013) 0.83
Seasonal maintenance of influenza vaccine-induced antibody response in kidney transplant recipients. Am J Nephrol (2012) 0.79
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions (1976) 9.68
Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology (1977) 7.10
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. Eur J Immunol (1981) 4.31
Effect of dosage and route of inoculation upon antigenicity of inactivated influenza virus vaccine (Hong Kong strain) in man. Bull World Health Organ (1969) 4.03
Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory. J Exp Med (1974) 2.54
Summary of clinical trials of influenza virus vaccines in adults. J Infect Dis (1977) 2.29
Effect of influenza vaccines in stimulating antibody in volunteers with prior immunity. Lancet (1973) 1.36
The effects of ACTH and cortisone on antibodies in human beings. Bull Johns Hopkins Hosp (1951) 1.31
Influenzal vaccine response in systemic lupus erythematosus. Ann Intern Med (1978) 1.11
Influenza vaccination in patients with rheumatic diseases. Safety and efficacy. JAMA (1979) 1.10
Impaired serum antibody response to inactivated influenza A and B vaccine in renal transplant recipients. Infect Immun (1977) 1.08
Corticosteroids and immunoglobulin synthesis. Transplant Proc (1975) 1.01
Effect of cyclosporin A on T-dependent and T-independent immunoglobulin synthesis in vitro. Nature (1980) 0.99
Response to influenza vaccine by renal transplant patients. Br Med J (1974) 0.94
Antibody response to influenza vaccination in renal transplant patients: correlation with allograft function. Ann Intern Med (1976) 0.93
The effect of ACTH and cortisone on the concentration of circulating diphtheria antitoxin. J Immunol (1952) 0.92
Influenza vaccination in renal transplant recipients. JAMA (1978) 0.89
Humoral and cell mediated immune response to bivalent influenza A/NJ/76 and A/Vict/75 vaccine in renal allograft recipients. Dev Biol Stand (1978) 0.83
Antibody response to influenza-virus vaccine in children with nephrosis: effect of cortisone. Pediatrics (1959) 0.81
The influence of cortisone and hydrocortisone on the production of circulating antibody in human beings. J Allergy (1953) 0.80
Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med (1971) 11.44
Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust (1985) 10.75
Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol (1986) 9.90
Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet (2003) 6.23
Semi-micro, dye-binding assay for rabbit interferon. Appl Microbiol (1971) 5.90
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Ultrastructural study of the behavior of macrophages toward parasitic mycobacteria. Infect Immun (1972) 5.12
Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J Exp Med (1975) 4.73
Unusual cellular fatty acids and distinctive ultrastructure in a new spiral bacterium (Campylobacter pyloridis) from the human gastric mucosa. J Med Microbiol (1985) 4.05
Prevention of phagosome-lysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1976) 3.98
A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut (2002) 3.73
Regulation of cellular interferon production: enhancement by antimetabolites. Proc Natl Acad Sci U S A (1970) 3.66
The ISWI chromatin-remodeling protein is required for gene expression and the maintenance of higher order chromatin structure in vivo. Mol Cell (2000) 3.62
Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation (1983) 3.60
Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer (1998) 3.55
Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. J Exp Med (1992) 3.30
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med (1975) 3.09
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy. Lancet (1984) 3.01
Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis (1991) 2.87
Polyadenylic acid sequences in the virion RNA of poliovirus and Eastern Equine Encephalitis virus. Science (1972) 2.78
Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis (1988) 2.76
On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride. J Gen Virol (1978) 2.50
A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med (1990) 2.50
The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis (1999) 2.49
Strain virulence and the lysosomal response in macrophages infected with Mycobacterium tuberculosis. Infect Immun (1974) 2.43
Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J Antimicrob Chemother (2001) 2.41
The pathophysiology of malaria. Adv Parasitol (1992) 2.33
Functional anatomy of lymph nodes. II. Peripheral lymph-borne mononuclear cells. Anat Rec (1978) 2.21
The role of lactoferrin in the bactericidal function of polymorphonuclear leucocytes. Immunology (1979) 2.20
Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J Infect Dis (1986) 2.18
Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. Infect Immun (1995) 2.05
Efficacy of cutting balloon angioplasty for lesions at the ostium of the coronary arteries. J Invasive Cardiol (1999) 2.04
Viral infections in renal transplant recipients. Infect Immun (1976) 2.03
Intramuscular ketamine for pediatric sedation in the emergency department: safety profile in 1,022 cases. Ann Emerg Med (1998) 2.02
Immunosuppression in Kenyan visceral leishmaniasis. Clin Exp Immunol (1983) 2.00
Sexual transmission efficiency of hepatitis B virus and human immunodeficiency virus among homosexual men. JAMA (1990) 2.00
The effect of calcium supplementation on bone density during lactation and after weaning. N Engl J Med (1997) 1.98
The mode of entry of vaccinia virus into L cells. J Gen Virol (1973) 1.94
Microbiological aspects of Helicobacter pylori (Campylobacter pylori). Eur J Clin Microbiol Infect Dis (1990) 1.93
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (Oxford) (2005) 1.91
Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study. Lancet (1991) 1.89
Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis (1985) 1.88
Difficult thoracic lesions: CT-guided biopsy experience in 150 cases. Radiology (1988) 1.87
Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis. Digestion (1987) 1.87
Malaria in splenectomized patients: report of four cases and review. Clin Infect Dis (1993) 1.85
Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes. J Clin Microbiol (1999) 1.77
A 5-year study of the seroepidemiology of Klebsiella pneumoniae: high prevalence of capsular serotype K1 in Taiwan and implication for vaccine efficacy. J Infect Dis (2000) 1.71
Virus infections after transplantation in man. Brief review. Arch Virol (1977) 1.70
C-type virus particles in pig kidney cell lines. J Gen Virol (1971) 1.67
No association between herpes simplex virus type-2 seropositivity or anogenital lesions and HIV seroconversion among homosexual men. J Acquir Immune Defic Syndr (1990) 1.67
Reactivation of murine cytomegalovirus by cyclophosphamide. Nature (1977) 1.67
Epidemiology of genital herpes in Pittsburgh: serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infections. J Infect Dis (1990) 1.67
Inactivation of viruses by benzalkonium chloride. Appl Microbiol (1964) 1.65
Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root. N Engl J Med (1979) 1.61
Interferon. Annu Rev Microbiol (1975) 1.61
Temporal trends in human immunodeficiency virus type 1 seroconversion 1984-1989. A report from the Multicenter AIDS Cohort Study (MACS). Am J Epidemiol (1991) 1.57
Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody. J Virol (1989) 1.55
V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression. Urology (2001) 1.54
Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelial cells under flow. Blood (2000) 1.54
Pasteurella multocida toxin activates the inositol triphosphate signaling pathway in Xenopus oocytes via G(q)alpha-coupled phospholipase C-beta1. J Biol Chem (1997) 1.53
Occurrence of cytomegalovirus hepatitis in liver transplant patients. J Med Virol (1988) 1.50
Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus. Infect Immun (1980) 1.50
Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA (1987) 1.49
Serum vitamin D metabolites in very low birth weight infants with and without rickets and fractures. J Pediatr (1989) 1.47
Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay. J Clin Microbiol (1992) 1.46
Efficacy of cutting balloon angioplasty for in-stent restenosis: an intravascular ultrasound evaluation. J Invasive Cardiol (2001) 1.46
McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol (2001) 1.45
Hepatitis C virus. Another agent transmitted by transplanted organs. N Engl J Med (1991) 1.45
Cellular origin of interferon induced by bacterial lipopolysaccharide. Infect Immun (1977) 1.44
Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J Infect Dis (1985) 1.43
Efficacy of directional coronary atherectomy before stent implantation for coronary ostial lesions. J Invasive Cardiol (2000) 1.42
Antibodies against haemorrhagic fever viruses in Kenya populations. Trans R Soc Trop Med Hyg (1983) 1.41
Accentuation of production of human interferon by metabolic inhibitors. Proc Soc Exp Biol Med (1972) 1.41
Dynamic alteration in splenic function during acute falciparum malaria. N Engl J Med (1987) 1.40
Will antibacterial chemotherapy be efficacious for gastritis and peptic ulcer? J Antimicrob Chemother (1986) 1.40
Enhancement of mouse cytomegalovirus infection during host-versus-graft reaction. Science (1975) 1.40
Promiscuity of clinical Plasmodium falciparum isolates for multiple adhesion molecules under flow conditions. J Immunol (1997) 1.39
Tolerance to the induction of interferons by endotoxin and virus: role of a humoral factor. Proc Soc Exp Biol Med (1965) 1.38
Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob Agents Chemother (2001) 1.38
A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjects. J Infect Dis (1978) 1.37
Resistance and susceptibility of mice to bacterial infection. IV. Genetic and cellular basis of resistance to chronic infection with Brucella abortus. J Infect Dis (1982) 1.34
Reduced erythrocyte survival following clearance of malarial parasitaemia in Thai patients. Br J Haematol (1987) 1.34
Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis (1991) 1.33
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid (1998) 1.33
Reactivation of herpes simplex virus after decompression of the trigeminal nerve root. J Infect Dis (1978) 1.32